Fundraising FoxMoat Biotechnology
Oklahoma City, US · Founded 2022 · Delaware LLC · 2 known investors
Find your way into Moat Biotechnology
Sign up to see every warm intro you have to Moat Biotechnology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Moat Biotechnology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RP
Russell P. RotherNamed on SEC filing
SA
Scott A. RollinsNamed on SEC filing
PJ
Philip JonesNamed on SEC filing
RA
Richard AlvarezNamed on SEC filing
Board
Investors · 2
Cortado VenturesreportedOklahoma City
How we know: a partner's Signal profile · funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 3 rounds · 2022–2025
▶$26.4KraisedOct 2025 · 1 investors · BiotechnologyRule 506(b)
▶$26.4KraisedOct 2025 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Russell P. RotherExecutive Officer, Director, Promoter
- Tetherex Pharmaceuticals CorporationPromoter
- Michael Moradi-AraghiDirector
- Scott A. RollinsExecutive Officer, Director, Promoter
- Todd FoleyDirector
- Phillip JonesDirector
- Offering amount
- $15.6M
- Amount sold
- $26.4K
- Minimum investment
- $26.4K
- Finders' fees
- $800K
- Proceeds to insiders
- $4.5M
- First sale
- Oct 2025
- Incorporated
- Limited Liability Company, Delaware, 2022
- Federal exemptions
- 06b
▶$101.6KraisedFeb 2023 · 2 investors · BiotechnologyRule 506(b)
▶$101.6KraisedFeb 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philip JonesDirector
- Richard AlvarezExecutive Officer
- Tetherex Pharmaceuticals CorporationPromoter
- Russell RotherExecutive Officer, Director, Promoter
- Scott A. RollinsExecutive Officer, Director, Promoter
- Todd FoleyDirector
- Offering amount
- $20M
- Amount sold
- $101.6K
- Minimum investment
- $50.8K
- Proceeds to insiders
- $3.1M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1.5MraisedOct 2022 · 2 investors · BiotechnologyRule 506(b)
▶$1.5MraisedOct 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philip JonesDirector
- Tetherex Pharmaceuticals CorporationPromoter
- Todd FoleyDirector
- Richard AlvarezExecutive Officer
- Scott RollinsExecutive Officer, Director, Promoter
- Russell RotherExecutive Officer, Director, Promoter
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $250K
- Proceeds to insiders
- $1.5M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Moat Biotechnology's investors?
- Moat Biotechnology's investors include Cortado Ventures, MPM BioImpact.
- How much funding has Moat Biotechnology raised?
- Moat Biotechnology has disclosed $1.6M raised across 3 rounds.
- Where is Moat Biotechnology headquartered?
- Moat Biotechnology is headquartered in Oklahoma City, US.